PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Attana AB

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Attana Signs Distribution Agreement with Izinta Trading Company Ltd - Attana AB has signed a distribution agreement with Izinta Trading Company Ltd for Hungarian market in the life science sector
Attana Signs Distribution Agreement with Izinta Trading Company Ltd

 

NewswireToday - /newswire/ - Stockholm, Sweden, 2009/03/16 - Attana AB has signed a distribution agreement with Izinta Trading Company Ltd for Hungarian market in the life science sector.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Attana AB, a leading supplier of the next generation biosensor for real time, label-free biosensor systems for molecular interactions studies, has signed a distribution agreement with Izinta Trading Company Ltd. a key distributor of high technology solutions in several life science applications, covering the entire Hungarian market in the life science sector.

Under the terms of agreement, Izinta will commence sales and marketing of Attana’s systems in Hungary beginning March 2009. Commenting on the agreement, Dr. Teodor Aastrup, CEO Attana said, “We are truly delighted to have come to an agreement with Izinta Trading Company Ltd. for coming onboard the distribution of our products. During the past seven years we have improved the Attana systems to be able to build a strong customer base in the European market. This agreement is naturally seen as the next logical step to accelerate our successful sales activities in Europe.”

“We see Attana as an innovative company that produces the next generation biosensor for high quality and high accuracy analysis. This has a unique product offering which complements our current product portfolio in a synergetic way to expand our presence in the market with the Attana biosensor systems,” commented Dr. Mihály Kramer Ph.D., CEO of Izinta.

About Izinta Trading Company Ltd

Izinta Trading Company Ltd. is an important Hungarian distributor company active mostly in the human, and veterinary diagnostic field, as well as in academic and RDbiotech and related research. Izinta’s products offer portfolio includes a wide variety of in vitro diagnostic devices, biochemical / molecular biological reagents, and hi-tech molecular biological instrumentation, among otherss,. veterinary diagnostics and instrumentation , nuclear medicine and their instruments, and basic plastic labware. The mMajor customer groups served by Izinta includes R and D departments of pharmaceutical companies, both human and veterinarian laboratories for basic and applied research laboratories, as well as, and hospital departments in nuclear medicine for surgery and diagnosisclinical and immunological diagnostics labs in hospitals. Incorporated in 1993, Izinta Trading Company Ltd. isoperates under also ISO certified (EN ISO 9001:2000 standards.

ABOUT Attana
Balancing Power and Simplicity in molecular interactions studies
Based in Stockholm, Sweden, Attana AB (attana.com) was founded with the goal of becoming a world leader within the sensor technologies for detecting, registering and measuring chemical and biochemical reactions. Based on the continuous-flow Quartz Crystal Microbalance (QCM) technology for real time, label-free molecular interaction studies, Attana has developed the next generation biosensor for high quality and high accuracy measurements. Attana believes in innovation, dedication, and being customer and solutions oriented in our operations and activities. Our systems have since 2003 been employed at leading universities and biotech companies in a wide variety of research fields within the life sciences in Europe and the USA.

ABOUT the Technology
Quartz Crystal Microbalance (QCM) can be explained as a very sensitive scale or balance capable of measuring atomic changes in mass. By applying an AC-potential to a piezoelectric quartz crystal, it can be controlled to oscillate at its resonance frequency. When molecules are added to, or removed from the surface, the change in the resonance frequency can be converted to a mass response. By immobilizing a specific molecule (the target) to the surface of the crystal and letting a sample flow over the surface, the target’s interaction with the sample can efficiently be studied in real time. The real time information provided can include detail kinetics, affinity, specificity, and active concentration determination data even in crude samples analysis.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Attana AB

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Attana Signs Distribution Agreement with Izinta Trading Company Ltd

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Alexander Kovacs, PhD. - Attana.com 
+46(0)8 410 200 00 alexander.kovacs[.]attana.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Attana AB securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Attana AB / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)